KYTO BIOPHARMA INC (KBPH) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 21 transactions totaling $4.6M, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Mar 16, 2021 involved a transaction of 181,250 shares valued at $5.4K.
No significant insider buying has been recorded for KBPH in the recent period.
No significant insider selling has been recorded for KBPH in the recent period.
Based on recent SEC filings, insider sentiment for KBPH is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
Insider trading at KYTO BIOPHARMA INC (KBPH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading KBPH stock, having executed 21 transactions in the past 90 days. The most active insider is Georges Benarroch (Executive), who has made 11 transactions totaling $2.6M.
Get notified when executives and directors at KBPH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 16, 2021 | Benarroch Georges | Executive | Option Exercise | 181,250 | $0.03 | $5.4K | |
| Apr 25, 2018 | Benarroch Georges | Executive | Other | 400,000 | $0.80 | $320.0K | |
| Feb 21, 2018 | Benarroch Georges | Executive | Other | 958,752 | $1.13 | $1.1M | Large |
| Feb 21, 2018 | Benarroch Georges | Executive | Other | 958,752 | $1.13 | $1.1M | Large |
| Sep 30, 2014 | Medarex Inc | Executive | Other | 1,300,000 | $N/A | $0 | |
| Sep 11, 2014 | Benarroch Georges | Executive | Award | 8,990,105 | $N/A | $0 | |
| Sep 11, 2014 | Benarroch Georges | Executive | Award | 100,000 | $N/A | $0 | |
| Sep 11, 2014 | Benarroch Georges | Executive | Award | 320,000 | $0.05 | $16.0K | |
| Sep 11, 2014 | Corp. Comindus Finance | Executive | Award | 7,905,840 | $0.05 | $395.3K | |
| Sep 11, 2014 | Corp. Comindus Finance | Executive | Disposition | 8,990,105 | $N/A | $0 | |
| Sep 11, 2014 | Corp. Comindus Finance | Executive | Conversion | 9,472,480 | $0.05 | $473.6K | |
| Sep 2, 2010 | Corp. Credifinance Capital | Executive | Other | 8,431,065 | $N/A | $0 | |
| Sep 2, 2010 | Benarroch Georges | Executive | Other | 8,431,065 | $N/A | $0 | |
| Dec 22, 2009 | Benarroch Georges | Executive | Purchase | 133,333 | $0.45 | $60.0K | |
| Dec 22, 2009 | Corp. Credifinance Capital | Executive | Sale | 133,333 | $0.45 | $60.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 9 | $2.5M | 31.2% |
Purchase(P) | 2 | $2.3M | 28.4% |
Sale(S) | 2 | $2.3M | 28.4% |
Award(A) | 5 | $493.0K | 6.1% |
Conversion(C) | 1 | $473.6K | 5.8% |
Exercise(M) | 1 | $5.4K | 0.1% |
Disposition(D) | 1 | $0 | 0.0% |
Insider activity at KYTO BIOPHARMA INC shows mixed signals across all time. While $2.3M in purchases indicates some executive confidence,$2.3M in sales balances the picture, resulting in a modest net flow of $0.5 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Georges Benarroch, has transacted $2.6M during this period.